切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2020, Vol. 17 ›› Issue (11) : 1090 -1094. doi: 10.3877/cma.j.issn.1672-6448.2020.11.007

所属专题: 文献

妇产科超声影像学

孕中期超声与甲状腺激素联合检查对诊断非匀称型胎儿宫内生长受限的价值
吕康泰1,(), 赵海静1, 邓红彬1, 陆青1, 王娟1, 吴海平1, 侯进军1, 罗钰铭1   
  1. 1. 210011 南京医科大学第二附属医院超声科
  • 收稿日期:2020-04-08 出版日期:2020-11-01
  • 通信作者: 吕康泰
  • 基金资助:
    江苏省妇幼健康科研项目(F201621)

Ultrasound combined with thyroid hormone detection for diagnosis of intrauterine growth restriction in asymmetrical fetuses in the second trimester of pregnancy

Kangtai Lyu1,(), Haijing Zhao1, Hongbin Deng1, Qing Lu1, Juan Wang1, Haiping Wu1, Jinjun Hou1, Yuming Luo1   

  1. 1. Department of Ultrasound, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China
  • Received:2020-04-08 Published:2020-11-01
  • Corresponding author: Kangtai Lyu
  • About author:
    Corresponding author: Lyu Kangtai, Email:
引用本文:

吕康泰, 赵海静, 邓红彬, 陆青, 王娟, 吴海平, 侯进军, 罗钰铭. 孕中期超声与甲状腺激素联合检查对诊断非匀称型胎儿宫内生长受限的价值[J]. 中华医学超声杂志(电子版), 2020, 17(11): 1090-1094.

Kangtai Lyu, Haijing Zhao, Hongbin Deng, Qing Lu, Juan Wang, Haiping Wu, Jinjun Hou, Yuming Luo. Ultrasound combined with thyroid hormone detection for diagnosis of intrauterine growth restriction in asymmetrical fetuses in the second trimester of pregnancy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(11): 1090-1094.

目的

探讨孕中期超声与甲状腺激素联合检查对诊断非匀称型胎儿宫内生长受限(IUGR)的价值。

方法

选取2016年6月至2019年6月在南京医科大学第二附属医院建立围产期保健卡的自然受孕单胎孕中期母胎6010例,其中胎儿为非匀称型IUGR者97例为观察组,同孕期胎儿生长均衡的孕母30例为对照组。分别采用Mann-Whitney U检验和独立样本t检验对比评价孕(18±1)周、(22±1)周,观察组与对照组母体血清促甲状腺激素(TSH)和游离甲状腺素(FT4)水平的差异。采用受试者操作特征(ROC)曲线分析孕(18±1)周和(22±1)周母体TSH和FT4预测胎儿生长迟缓的价值。

结果

观察组母体(18±1)周和(22±1)周时FT4水平低于对照组[(10.74±2.87)pmol/L vs(14.83±1.91)pmol/L;(11.96±2.87)pmol/L vs(15.28±2.14)pmol/L],差异均具有统计学意义(t=-6.978、-6.793,P均<0.001);观察组母体(22±1)周时TSH水平高于对照组[2.52(1.74~3.21)mlU/ml vs 1.96(1.54~2.76)mlU/ml],差异有统计学意义(Z=-2.191,P=0.028);(18±1)周时2组母体TSH水平比较,差异无统计学意义(P>0.05)。孕(18±1)周、(22±1)周时母体FT4预测胎儿生长迟缓的敏感度均大于95%,分别为96.7%和100%,显著高于TSH(32.4%和55.2%);但母体TSH预测胎儿生长迟缓的特异度(90.0%和73.3%)却高于FT4(75.7%和56.2%)。

结论

孕中期超声与甲状腺激素联合检查对非匀称型IUGR具有一定的预测价值。

Objective

To evaluate the diagnostic value of mid-pregnancy ultrasound combined with thyroid hormone examination for asymmetrical fetal intrauterine growth restriction (IUGR).

Methods

A total of 6010 naturally conceived single fetuses in the second trimester of gestation were selected at the Second Affiliated Hospital of Nanjing Medical University from June 2016 to June 2019, among which 97 cases of fetuses with asymmetrical IUGR were included in an observation group. Thirty cases of fetuses during normal pregnancy were included in a control group. Mann-Whitney U test and independent sample t test were used to compare the difference of maternal serum thyroid stimulating hormone (TSH) and free thyroxine (FT4) between the observation group and the control group at (18±1) weeks and (22±1) weeks of pregnancy. The receiver operating characteristic (ROC) curve was used to analyze the value of maternal TSH and FT4 in predicting fetal growth retardation at (18±1) weeks and (22±1) weeks of gestation.

Results

The FT4 levels of the observation group were significantly lower than those of the control group at (18±1) weeks and (22±1) weeks [(10.74±2.87) pmol/L vs (14.83±1.91) pmol/L, t=-6.978, P<0.001; (11.96±2.87) pmol/L vs (15.28±2.14) pmol/L, t=-6.793, P<0.001], but TSH was significantly higher in the observation group than in the control group at (22±1) weeks [2.52 (1.74~3.21) mIU/ml vs 1.96 (1.54~2.76) mIU/ml, Z=-2.191, P=0.028]. There was no significant difference in maternal TSH between the two groups at 18±1 weeks (P>0.05). At (18±1) weeks and (22±1) weeks, the sensitivities of maternal FT4 in predicting fetal growth retardation were 96.7% and 100%, respectively, which were significantly higher than those of TSH (32.4% and 55.2%). However, maternal TSH predicted fetal growth retardation more specifically than FT4 (90.0% vs 75.7%, 73.3% vs 56.2%).

Conclusion

Ultrasound combined with thyroid hormone detection has appreciated predictive value for asymmetrical IUGR in the second trimester of pregnancy.

表1 孕(18±1)周和孕(22±1)周母体甲状腺功能生物标记物检查结果(例)
表2 观察组和对照组孕(18±1)周和孕(22±1)周母体甲状腺功能生物标记物检查结果比较
图1 两阶段母体促甲状腺激素和游离甲状腺素预测胎儿生长迟缓的受试者操作特征(ROC)曲线。图a为(18±1)周时促甲状腺激素的ROC曲线,图b为(18±1)周时游离甲状腺激素的ROC曲线,图c为(22±1)周时促甲状腺激素的ROC曲线,图d为(22±1)周时游离甲状腺激素的ROC曲线
1
陈海燕. 不同孕周产前超声筛查胎儿畸形的临床价值 [J]. 中国医药指南, 2014, 29(4): 324-324.
2
张晓新,许翠平,任秀珍, 等. 中晚孕期产前超声筛查胎儿畸形的临床价值 [J/CD]. 中华临床医师杂志(电子版), 2010, 4(5): 558-562.
3
肖作源,唐新意,陈裕明, 等. 小于胎龄儿临床分型及其与围生期因素相关性探讨 [J]. 中国实用儿科杂志, 2003, 18(7): 408-410.
4
Wier FA, Farley CL. Clinical controversies in screening women for thyroid disorders during pregnancy [J]. J Midwifery Womens Health, 2006, 51(3): 152-158.
5
黄林环,方群,谢红宁, 等. 胎儿短长骨的产前诊断及临床分析 [J]. 中华医学杂志, 2007, 87(45): 3178-3182.
6
朱毓纯,孙瑜,杨慧霞, 等. 胎儿股骨短的临床意义和处理 [J]. 中华围产医学杂志, 2015, 18(4): 313-314.
7
严英榴,杨秀雄. 产前超声诊断学 [M]. 2版. 北京: 人民卫生出版社, 2012: 415-424.
8
Ashoor G, Maiz N, Rotas M, et al. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death [J]. Thyroid, 2010, 20(9): 989-993.
9
唐慧霞,李胜利. 超声估测胎儿体重的研究进展 [J/CD]. 中华医学超声杂志(电子版), 2014, 11(5): 369-374.
10
李海朋,庞远,董亚男, 等. 彩超检测胎儿骨骼发育迟缓与孕妇甲状腺激素水平的研究[J]. 中国煤炭工业医学杂志, 2017, 20(2): 173-175.
11
代晶. 产前超声诊断胎儿股骨短小的研究进展 [J/CD]. 中华妇幼临床医学杂志(电子版), 2014, 10(3): 105-108.
12
Morreale de Escobar G, Obregón MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? [J]. J Clin Endocrinol Metab, 2000, 85(11): 3975-3987.
13
Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development [J]. Eur J Endocrinol, 2004, 151 Suppl 3: U25-U37.
14
孙丽洲,姜子燕. 妊娠合并慢性淋巴细胞性甲状腺炎 [J]. 中国实用妇科与产科杂志 , 2007, 23(12): 915-917.
15
姜云生,王崇丹. 妊娠期甲状腺功能减退症的诊治进展 [J]. 齐齐哈尔医学院学报 , 2011(23): 3880-3882.
16
Gil-Garay R, Miralles-Flores C, Obregón MJ, et al. Maternal hypothyroidism and fetal chondro-osseous development in rats [J]. Biol Neonate, 1991, 60(6): 385-394.
17
Lanham SA, Fowden AL, Roberts C, et al. Effects of hypothyroidism on the structure and mechanical properties of bone in the ovine fetus [J]. J Endocrinol, 2011, 210(2): 189-198.
18
马品江,孙燕,郭进军. 吐鲁番盆地碘缺乏病区孕妇碘营养与胎儿生长发育关系的研究[J]. 实用预防医学 , 2009, 16(5): 1448-1451.
19
Farquharson C. Social networking between cells of the foetal skeleton: the importance of thyroid hormones [J]. J Endocrinol, 2011, 210(2): 135-136.
[1] 张婉微, 秦芸芸, 蔡绮哲, 林明明, 田润雨, 金姗, 吕秀章. 心肌收缩早期延长对非ST段抬高型急性冠脉综合征患者冠状动脉严重狭窄的预测价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1016-1022.
[2] 任书堂, 刘晓程, 张亚东, 孙佳英, 陈萍, 周建华, 龙进, 黄云洲. 左心室辅助装置支持下单纯收缩期主动脉瓣反流的超声心动图特征[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1023-1028.
[3] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[4] 薛艳玲, 马小静, 谢姝瑞, 何俊, 夏娟, 何亚峰. 左心声学造影在急性心肌梗死合并室间隔穿孔中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1036-1039.
[5] 吕琦, 惠品晶, 丁亚芳, 颜燕红. 颈动脉斑块易损性的超声造影评估及与缺血性卒中的相关性研究[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1040-1045.
[6] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1046-1055.
[7] 武玺宁, 欧阳云淑, 张一休, 孟华, 徐钟慧, 张培培, 吕珂. 胎儿心脏超声检查在抗SSA/Ro-SSB/La抗体阳性妊娠管理中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1056-1060.
[8] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[9] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[10] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[11] 丁雷, 罗文, 杨晓, 庞丽娜, 张佩蒂, 刘海静, 袁佳妮, 刘瑾. 高帧频超声造影在评价C-TIRADS 4-5类甲状腺结节成像特征中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(09): 887-894.
[12] 张茜, 陈佳慧, 高雪萌, 赵傲雪, 黄瑛. 基于高帧频超声造影的影像组学特征鉴别诊断甲状腺结节良恶性的价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 895-903.
[13] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[14] 赵文毅, 邹冰子, 蔡冠晖, 刘永志, 温红. 超声应变力弹性成像联合MRI-DWI靶向引导穿刺在前列腺病变诊断中的应用[J]. 中华临床医师杂志(电子版), 2023, 17(9): 988-994.
[15] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
阅读次数
全文


摘要